Icelandic Salmon AS - Minutes of Annual General Meeting 2025 The annual general meeting of Icelandic Salmon AS (the "Company") was held on 18 June 2025 at 11:00 (CEST). All resolutions were approved as proposed by the board. Please find the minutes including appendices enclosed. The documents are also made available on the Company's website . For more information, please contact: Björn Hembre, CEO. Tel: This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment
Icelandic Salmon AS - Notice of Annual General Meeting 2025 Bíldudalur, 4 June 2025 The annual general meeting of Icelandic Salmon AS (the "Company") will be held on 18 June 2025 at 11:00 (CEST). Please find the notice including appendices enclosed. The documents are also made available on the Company's website . For more information, please contact: Björn Hembre, CEO. Tel: This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments ...
Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...
Organizational change in Arnarlax ehf Agreement has been made with directors for Finance, Jónas Heiðar Birgisson, and Biology, Rolf Ørjan Nordli, to step down from their positions as a part of organizational reorganization. Replacement in the position as CFO is Edvin Aspli, which has over the last months served as Chief Strategic Officer and has previous experience from the aquaculture team in Kverva AS, for 3 years. Edvin goes in as acting CFO, until permanent CFO is in place. That process will start immediately. Replacement for position as COO Biology will be Johnny Indergård, that ha...
Icelandic Salmon – Challenging first quarter Bíldudalur, 20 May 2025 Icelandic Salmon is the parent company of Arnarlax and its subsidiaries, which are involved in salmon farming and processing in Iceland. The companies are collectively referred to as "Icelandic Salmon" or the "Group". In the first quarter, Icelandic Salmon experienced biological challenges at sea. To protect animal welfare, some volumes were harvested early at low average weights. Results were marked by mortality-related costs, low harvest volumes, and a weaker market due to increased global supply and lower prices. Ope...
Icelandic Salmon – Invitation to presentation for the first quarter 2025 results Bíldudalur, 19 May 2025 Icelandic Salmon will be presenting its results for the first quarter of 2025 tomorrow on Tuesday, 20 May 2025. The presentation will be held in English via webcast. Please copy and paste the following link into your browser: . CEO Bjørn Hembre and CFO Jónas Heiðar Birgisson will present the results at 9:00 Icelandic time (11:00 CEST). A Q&A session will follow, and questions can be submitted before and during the presentation to . One-on-one meetings can be arranged either in our of...
A director at Ambu AS bought 2,800 shares at 15.412USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.